Hepatic arterial infusion (HAI) of fixed dose rate gemcitabine in patients with liver metastases from colorectal carcinoma. A phase I study with pharmocokinetic analysis

被引:0
|
作者
Leonard, Gregory D. [1 ]
Sperber, Daniella [1 ]
O'Connor, Owen [1 ]
Kemeny, Nancy E. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:245 / 245
页数:1
相关论文
共 50 条
  • [31] A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors
    Mortazavi, Amir
    Ling, Yonghua
    Martin, Ludmila Katherine
    Wei, Lai
    Phelps, Mitch A.
    Liu, Zhongfa
    Harper, Erica J.
    Ivy, S. Percy
    Wu, Xin
    Zhou, Bing-Sen
    Liu, Xiyong
    Deam, Deidre
    Monk, J. Paul
    Hicks, William J.
    Yen, Yun
    Otterson, Gregory A.
    Grever, Michael R.
    Bekaii-Saab, Tanios
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 685 - 695
  • [32] A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors
    Amir Mortazavi
    Yonghua Ling
    Ludmila Katherine Martin
    Lai Wei
    Mitch A. Phelps
    Zhongfa Liu
    Erica J. Harper
    S. Percy Ivy
    Xin Wu
    Bing-Sen Zhou
    Xiyong Liu
    Deidre Deam
    J. Paul Monk
    William J. Hicks
    Yun Yen
    Gregory A. Otterson
    Michael R. Grever
    Tanios Bekaii-Saab
    Investigational New Drugs, 2013, 31 : 685 - 695
  • [33] Phase I/II study of irinotecan, UFT, and leucovorin with hepatic arterial infusion in colorectal cancer patients with unresectable liver metastases: Preliminary results
    Yamaguchi, T.
    Matsumoto, H.
    Takahashi, K.
    Yasutome, M.
    Mori, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Salvage intra-arterial (HAI) chemotherapy in patients affected from hepatic metastases from colorectal carcinoma (CRC)
    Bareggi, C.
    Garassino, M. C.
    De Braud, F.
    Zampino, G.
    Crepaldi, C.
    Salamina, S.
    Colombo, A.
    Pancera, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 44 - 45
  • [35] Hepatic arterial infusion (HAI) compared to systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma: A systematic review and meta-analysis of randomized controlled trials
    Mocellin, S.
    Pilati, P.
    Lise, M.
    Nitti, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
    Kemeny, N.
    Capanu, M.
    D'Angelica, M.
    Jarnagin, W.
    Haviland, D.
    Dematteo, R.
    Fong, Y.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1236 - 1241
  • [37] Hepatic arterial infusion of Floxuridine and Dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma
    Kemeny, N
    Eid, A
    Stockman, J
    Gonen, M
    Schwartz, L
    Tetzlaff, E
    Paty, P
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (02) : 97 - 101
  • [38] Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer
    Fallik, D
    Ychou, M
    Jacob, J
    Colin, P
    Seitz, JF
    Baulieux, J
    Adenis, A
    Douillard, JY
    Couzigou, P
    Mahjoubi, R
    Ducreux, M
    Mahjoubi, M
    Rougier, P
    ANNALS OF ONCOLOGY, 2003, 14 (06) : 856 - 863
  • [39] Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: A phase II clinical study
    Fiorentini, G
    Rossi, S
    Denticol, P
    Bernardeschi, P
    Calcinai, A
    Bonechi, F
    Cantore, M
    Guadagni, S
    De Simone, M
    TUMORI JOURNAL, 2003, 89 (04): : 382 - 384
  • [40] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic carcinoma
    Espinosa, E.
    Feliu, J.
    de Castro, J.
    Belda, C.
    Casado, E.
    Herrero, A.
    Sereno, M.
    Pinto, A.
    Gomez, C.
    Baron, M. Gonzalez
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)